The case reflects on Pedro's situation, then C-level executive of the international pharmaceutical company CAF, when in 2015 he and the executive team realize the need to rethink their growth model and overall strategy. With 250 employees and 80 million Euros in revenue, the pride they felt for their success to this date couldn't keep them away from the certainty of needing to steer the wheel. They where considering several growth options that ranged from venturing into other medical specialties, to exporting their business model to other countries or even the possibility of using their factory to manufacture products to third parties. With all of this in mind, they also realized the need to grow their executive team, without still knowing how to face these new challenges.